HIGHLIGHTS
- who: Lupus Erythematosus and colleagues from the Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, st Department have published the article: Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus, in the Journal: (JOURNAL) of 24/02/2021
SUMMARY
The programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) pathway is one of the numerous cell signaling mechanisms that regulate complex immunological communication between immune and parenchymal cells. Targets of these therapies are the PD-1 receptor and its ligand, PD-L1, two key . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.